Literature DB >> 6368606

Endotoxaemia as a cause of fever in immunosuppressed patients.

R I Harris, P C Stone, G R Evans, J Stuart.   

Abstract

Using a recently developed chromogenic substrate assay sensitive to 10 pg/ml Escherichia coli endotoxin in plasma, systemic endotoxaemia was found in 52% of 21 episodes of fever in patients with a haematological malignancy who were infected. Endotoxaemia was also found in 27% of 22 episodes of fever of unknown origin. In 45 afebrile patients neither neutropenia nor cytotoxic chemotherapy was a cause of endotoxaemia. Passage of endotoxin from portal blood into the systemic circulation can contribute to unexplained fever in immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368606      PMCID: PMC498754          DOI: 10.1136/jcp.37.4.467

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Control of spillover. The importance of Kupffer-cell function in clinical medicine.

Authors:  J W Bradfield
Journal:  Lancet       Date:  1974-10-12       Impact factor: 79.321

2.  Hepatic lysosomes and the inactivation of endotoxin.

Authors:  J P Filkins
Journal:  J Reticuloendothel Soc       Date:  1971-05

3.  An improved chromogenic substrate endotoxin assay for clinical use.

Authors:  R I Harris; P C Stone; J Stuart
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

4.  A comparison of pyrogenicity of bacterial endotoxins from a variety of Gram-negative bacteria as determined by the LAL test.

Authors:  J Fleishman; F Fowlkes
Journal:  Prog Clin Biol Res       Date:  1982

5.  Hepatic clearance of endotoxins: differences in arterial and portal venous infusion.

Authors:  J Wolter; H Liehr; M Grün
Journal:  J Reticuloendothel Soc       Date:  1978-02

6.  Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis.

Authors:  H Prytz; J Holst-Christensen; B Korner; H Liehr
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

7.  Investigations on the specificity of the Limulus test for the detection of endotoxin.

Authors:  A Wildfeuer; B Heymer; K H Schleifer; O Haferkamp
Journal:  Appl Microbiol       Date:  1974-11

8.  Serial study of C-reactive protein during infection in leukaemia.

Authors:  P E Rose; S A Johnsdon; M Meakin; P H Mackie; J Stuart
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

  8 in total
  9 in total

1.  Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern.

Authors:  P Engervall; M Granström; B Andersson; M Kalin; M Björkholm
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

2.  Endotoxin testing revisited.

Authors:  A Sturk; J W ten Cate
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

3.  Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium.

Authors:  M J Rogers; J Cohen
Journal:  Infection       Date:  1986 Mar-Apr       Impact factor: 3.553

4.  Does gram-negative bacteraemia occur without endotoxaemia? A meta-analysis using hierarchical summary ROC curves.

Authors:  J C Hurley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-29       Impact factor: 3.267

5.  Antithrombin III in the diagnosis of infection in febrile neutropenic patients.

Authors:  C C Kibbler; H G Prentice; P Noone
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

6.  Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid.

Authors:  W Wellmann; P C Fink; F Benner; F W Schmidt
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

7.  Endogenous endotoxemia in patients with liver cirrhosis--a quantitative analysis of endotoxin in portal and peripheral blood.

Authors:  G Tachiyama; M Sakon; J Kambayashi; S Iijima; T Tsujinaka; T Mori
Journal:  Jpn J Surg       Date:  1988-07

8.  Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.

Authors:  G Behre; I Schedel; B Nentwig; B Wörmann; M Essink; W Hiddemann
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

9.  Microbial translocation contribute to febrile episodes in adults with chemotherapy-induced neutropenia.

Authors:  Michelle Wong; Babilonia Barqasho; Lars Ohrmalm; Thomas Tolfvenstam; Piotr Nowak
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.